Wall St Price Targets

0RPS Price Forecast
Based on 8 analysts

+18% Upside
from kr261 today

Medicover AB (0RPS)’s 12-month stock price forecast through November 2027 has a consensus target of kr307.15, implying 18% upside. The forecast is based on price targets from 8 Wall Street analysts.

0RPS Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 0RPS yet.

Medicover AB Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0RPS's stock price target?
Price Target
307.15 SEK

According to Wall Street analysts, the average 1-year price target for 0RPS is 307.15 SEK with a low forecast of 241.28 SEK and a high forecast of 358.34 SEK.

What is the Revenue forecast for Medicover AB?
Projected CAGR
13%

Over the last 9 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 5 years is 13%.

What is the Gross Profit forecast for Medicover AB?
Projected CAGR
13%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 5 years is 13%.

What is the Operating Income forecast for Medicover AB?
Projected CAGR
18%

Over the last 9 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 8 years is 18%.

What is the Pre-Tax Income forecast for Medicover AB?
Projected CAGR
33%

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 33%.

What is the Net Income forecast for Medicover AB?
Projected CAGR
30%

Over the last 9 years, the compound annual growth rate for Net Income has been 32%. The projected CAGR for the next 3 years is 30%.

Back to Top